Could Stem Cell Therapy be the Answer to Your Autoimmune Disease? Let’s Explore
If you, or someone you love, is grappling with an autoimmune disease, it’s natural to explore every possible avenue to manage or potentially reverse its effects. This article aims to shed light on one of the emerging treatment options – stem cell therapy. Autoimmune diseases are conditions where the body’s own immune system mistakenly attacks […]
Say Goodbye to Pain: 5 Amazing Benefits of Stem Cell Therapy
In recent years, stem cell therapy has emerged as a groundbreaking treatment option for various chronic conditions and injuries. This innovative approach utilizes the body’s natural healing abilities to help alleviate pain, promote recovery, and improve overall health. In this article, we’ll explore the science behind stem cell therapy and discuss five amazing benefits that […]
A New Era in Pain Management: CELL Technologies Pursues Groundbreaking Stem Cell Therapy Approval
CELL Technologies Inc. has submitted clinical data from its stem cell program for pain management to Health Canada for approval. This follows a regulatory meeting on March 31st, 2023, and if approved, CELL would become the first regulatory-approved stem cell provider in North America. The data submitted covers three studies in arthritis, degenerative disc disease, […]
Stem Cell Treatment: A Safe Option for Arthritis Patients?
Stem cell therapy has become a popular treatment option for many medical conditions, including arthritis. But does it work? In this blog post, we’ll explore the potential benefits of stem cell therapy for arthritis and discuss what the research says. What is Arthritis? Arthritis is an inflammatory condition that affects the joints, with effects that […]
Clinical Evidence on Stem Cell Therapy – Dr. Joy Kong
Recording of Dr Joy Kong speaking at the 9th Annual International Cell Surgical Conference about the clinical evidence that currently exists in stem cell treatments.
Regenerative Medicine Treatment Options
In this webinar replay, Dr. Siddharth Tambar from Chicago Arthritis and Regenerative Medicine reviews regenerative treatment options in details and answers audience questions. Video Transcript: Hello, everyone – this is Siddharth Tambar from Chicago Arthritis and Regenerative Medicine. Welcome to our webinar today on regenerative medicine treatments. As I’m talking, I’ve got a little bit […]
Stem Cell Therapy vs PRP Injection
Stem Cell Therapy vs PRP Injection – Which is better? Platelet rich plasma injections and stem cell injections are revolutionizing the way we treat orthopedic problems. Both have been shown in clinical trials to provide excellent pain relief and reduction of symptoms related to symptomatic knee osteoarthritis. However, there have been no trials directly comparing […]
Regenerative Medicine: The New Frontier in Healing with Special Guest Dr. Stuart Kauffman, DO
In this episode of Dr. Smith Live, Dr. Stuart Kauffman is the featured guest and shares some great information regarding today’s use of regenerative medicine. Topics discussed include: • Incredible regenerative effect of stem cells • Advantages of using growth factor with stem cell treatment • Best ways to treat sport injuries without drugs • […]
Does umbilical cord stem cell therapy work for knee arthritis?
Stem cells have been getting a lot of hot press lately as a promising treatment option for chronic musculoskeletal pain. More and more studies are looking at how stem cells can be used to treat conditions such as arthritis. But what about umbilical cord derived stem cells? Well in this video, Dr Jeff Peng goes […]
Immunis Announces FDA Clearance and Clinical Site for Phase 1/2a Clinical Trial Investigating Immune-Mediated Muscle Atrophy
IRVINE, Calif., Aug. 9, 2022 /PRNewswire/ — Immunis Inc., a private biotechnology company developing a novel treatment for age and disease-related immune decline, today announced that the U.S. Food and Drug Administration has approved it’s Investigational New Drug application for a Phase 1/2a clinical trial investigating IMM01-STEM in participants with muscle atrophy: www.clinicaltrials.gov/ct2/show/NCT05211986 The open label […]